Skip to content

Personalized medicine research based on lung cancer organoid technology

Personalized medicine research based on lung cancer organoid technology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060777
Enrollment
Unknown
Registered
2022-06-11
Start date
2022-07-08
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Case series:None

Sponsors

Zhongshan Hospital Affiliated to Dalian University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Lung cancer patients of any clinical stage confirmed by histology or highly suspected by imaging; 2. Age >= 18 years, gender is not limited; 3. Consent to participate in the study, read written informed consent and sign informed consent prior to any study related procedures; 4. Biopsy and/or surgical samples of metastases and/or original tumors may be obtained; 5. All types of resections are eligible, such as wedge resection, segmentectomy, lobectomy, pneumonectomy; 6. Able and willing to complete questionnaires regarding their environmental/occupational exposure and smoking/drinking history.

Exclusion criteria

Exclusion criteria: 1. There is insufficient lung tissue for histological analysis or the remaining lung tissue is insufficient for routine pathological analysis; 2. The general condition is poor and cannot tolerate surgery without improvement after medical treatment; 3. Other foreseeable pathological conditions that lead to surgical risk and postoperative dysfunction; 4. Received induction therapy (such as induction chemotherapy or chemoradiotherapy) before; 5. According to the judgment of the attending physician, the patient will not be able to meet the requirements of the study.

Design outcomes

Primary

MeasureTime frame
Organoid number and size;

Countries

China

Contacts

Public ContactRuoyu Wang

Zhongshan Hospital Affiliated to Dalian University

wangruoyu1963@163.com+86 411 62893970

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026